Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry

Cancer PainPain ReliefLabor and Delivery

Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-Up Study Over an 11-Year Period in a Comprehensive Cancer Center

Anesth Analg.

Carvajal G, Dupoiron D, Seegers V, Lebrec N, Boré F, Dubois PY, Leblanc D, Delorme T, Jubier-Hamon S

doi: 10.1213/ANE.

Cancer Pain

The Rate of Infectious Complications After Intrathecal Drug Delivery System Implant for Cancer-Related Pain Is Low Despite Frequent Concurrent Anticancer Treatment or Leukopenia

Anesth Analg.

Sindt JE, Larsen SD, Dalley AP, Collier WH, Brogan SE

doi: 10.1213/ANE.0000000000004639.

Cancer Pain

Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy

Anesth Analg.

Brogan SE, Sindt JE, Jackman CM, White J, Wilding V, Okifuji A

doi: 10.1213/ANE.

RECOMMENDED

Acute PainPostoperative Pain

Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study

Reg Anesth Pain Med.

Habib AS, Kertai MD, Cooter M, Greenup RA, Hwang S

doi: 10.1136/rapm-2018-000040.

Cancer Pain

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study

J Clin Med.

Cuomo A, Cascella M, Forte CA, Bimonte S, Esposito G, De Santis S, Cavanna L, Fusco F, Dauri M, Natoli S, Maltoni M, Morabito A, Mediati RD, Lorusso V, Barni S, Porzio G, Mercadante S, Crispo A

doi: 10.3390/jcm9041003.

Cancer Pain

Factors influencing the use of opioids for breakthrough cancer pain: a secondary analysis of the IOPS-MS study

Eur J Pain.

Mercadante S, Adile C, Masedu F, Marchetti P, Costanzi A, Aielli F

doi: 10.1002/ejp.1339.

Cancer PainNeuropathic Pain

Multiple effectiveness aspects of tapentadol for moderate-severe cancer-pain treatment: an observational prospective study

J Pain Res.

Cascella M, Forte CA, Bimonte S, Esposito G, Romano C, Costanzo R, Morabito A, Cuomo A

doi: 10.2147/JPR.S181079.

Cancer PainNeuropathic Pain

Neuropathic pain: clinical classification and assessment in patients with pain due to cancer

Pain.

Shkodra M, Brunelli C, Zecca E, Formaglio F, Bracchi P, Lo Dico S, Caputo M, Kaasa S, Caraceni A

doi: 10.1097/j.pain.0000000000002076.

COMMENTED

Chronic PainNeuropathic PainPostoperative Pain

Pain-related functional interference in patients with chronic neuropathic postsurgical pain: an analysis of registry data

Pain.

Stamer UM, Ehrler M, Lehmann T, Meissner W, Fletcher D

doi: 10.1097/j.pain.

Related content

Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-Up Study Over an 11-Year Period in a Comprehensive Cancer Center

The Rate of Infectious Complications After Intrathecal Drug Delivery System Implant for Cancer-Related Pain Is Low Despite Frequent Concurrent Anticancer Treatment or Leukopenia

Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy

Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study

Factors influencing the use of opioids for breakthrough cancer pain: a secondary analysis of the IOPS-MS study

Multiple effectiveness aspects of tapentadol for moderate-severe cancer-pain treatment: an observational prospective study

Neuropathic pain: clinical classification and assessment in patients with pain due to cancer

Pain-related functional interference in patients with chronic neuropathic postsurgical pain: an analysis of registry data